Educational Activities

DNA Educational Activities

Welcome to our online issues of Dermatology Nurse Practice

This is a series of print and online educational resources that is developed by the Dermatology Nurses’ Association thanks to unrestricted educational grants from Incyte and Pfizer. We hope that you find the information in this and subsequent publications of informational and educational value as you progress in your career as a dermatology nurse. If there are topics you’d like to learn about in the future or if you have any feedback on this education, please don’t hesitate to drop us a note at dna@dnanurse.org. We’d love to hear from you!

This Education Offering is provided FREE of charge!

The Dermatology Nurses’ Association (DNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

VOLUME 1 | ISSUE 3

Release Date: July 15, 2022

Expiration Date: July 15, 2023

INSIDE THIS ISSUE:

Why are systemic therapies so important to help control disease activity in patients with moderate to severe atopic dermatitis (AD)?

How has the introduction of dupilumab changed the short- and long-term prognosis of patients with moderate to severe AD?

What impact might the recent introduction of additional FDA approved systemic therapies have on the care of patients with moderate to severe AD?

What are some of the class specific safety concerns with systemic agents either recently approved or under late-stage investigation for the treatment of AD?

VOLUME 1 | ISSUE 2

Release Date: June 1, 2022

Expiration Date: June 1, 2023

INSIDE THIS ISSUE:

What exactly is a “healthcare disparity?”

How is the clinical appearance of atopic dermatitis (AD) lesions among patients with skin of color unique?

What is known about the prevalence of hypopigmentation and skin atrophy among AD patients with skin of color?

Why is it a bad idea to let family members serve as medical translators for patients who are non-native English speakers?

VOLUME 1 | ISSUE 1

Release Date: December 15, 2021

Expiration Date: December 15, 2022

INSIDE THIS ISSUE:

What is driving the increased prevalence of atopic dermatitis (AD) both in the United States and around the globe?

What are the differences between the “inside-out” and “outside-in” theories that have been proposed to help explain why AD develops in some individuals but not others?

How common is the “atopic march” among infants who are diagnosed with AD?

What are some of the more common pathways targeted by therapies commonly used to treat AD?